What is the current Erythrocyte Sedimentation Tube market size?

The Erythrocyte Sedimentation Tube market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Erythrocyte Sedimentation Tube market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Erythrocyte Sedimentation Tube market?

Increasing demand for diagnostic tests and rising awareness of chronic diseases drive the market.

What challenges does the Erythrocyte Sedimentation Tube market face?

Stringent regulations and high manufacturing costs pose significant challenges.

Which regions lead the Erythrocyte Sedimentation Tube market?

North America and Europe are the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the Erythrocyte Sedimentation Tube market?

Leading companies include Thermo Fisher Scientific and BD Biosciences.

What future opportunities exist in the Erythrocyte Sedimentation Tube market?

Emerging economies and technological advancements present significant future opportunities.

How does technology impact the Erythrocyte Sedimentation Tube market?

Advances in automation and point-of-care testing drive market growth.

What is the regulatory landscape of the Erythrocyte Sedimentation Tube market?

Regulations vary by region, with FDA and CE markings required for market entry.

What is the future outlook for the Erythrocyte Sedimentation Tube market?

The future outlook is positive, with increasing demand for diagnostic tests driving growth.

Erythrocyte Sedimentation Tube Trends, Opportunities & Forecast 2033

Erythrocyte Sedimentation Tube by Application (Hospital, Specialist Center, Other), by Types (Plastic, Grass), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Erythrocyte Sedimentation Tube Market Overview

The Erythrocyte Sedimentation Tube market refers to the industry involved in the production and distribution of tubes used to measure the sedimentation rate of erythrocytes, or red blood cells, in a blood sample. As a crucial tool in medical diagnostics, the Erythrocyte Sedimentation Tube market size is estimated to be around $234 million in 2025. The growth outlook for this market is positive, with a market forecast indicating a compound annual growth rate (CAGR) of 4.5% from 2026 to 2033, driven by an increasing demand for diagnostic tests and a growing awareness of the importance of early disease detection. The industry expansion is expected to be driven by advancements in technology, changes in regulations, and shifting consumer behavior, with the largest region being North America and the fastest-growing region being the Asia-Pacific.

Loading chart…

The Erythrocyte Sedimentation Tube market is shaped by several key forces, including technology shifts towards more accurate and efficient diagnostic tests, regulations regarding the use of certain materials in medical devices, and consumer behavior driven by an increasing awareness of the importance of early disease detection. The competitive intensity in the market is moderate, with several major players competing for market share, and the supply-chain dynamics are influenced by the availability of raw materials and the demand for diagnostic tests. Overall, the Erythrocyte Sedimentation Tube market is expected to experience steady growth over the next few years, driven by the increasing demand for diagnostic tests and the growing awareness of the importance of early disease detection.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.94 billion
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Greiner Bio-One; DWK Life Sciences; ELITechGroup; Thomas Scientific; Streck; Geisinger Health System; SOL-Millennium; Hangzhou Hanshuo Medical Equipment; Zhejiang Gongdong Medical Equipment; ESBE Scientific Industries Inc.; Medline Industries, Inc.; Kartell Spa; SANLI Medical; DD Biolab; Vacutest Kima; Labcorp; AL-Hanoof
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Erythrocyte Sedimentation Tube market is poised for significant growth, driven by increasing demand for diagnostic tests and growing awareness about the importance of early disease detection. The market dynamics are influenced by various factors, which are outlined below.

Growth Drivers2 items

Advances in technology have led to the development of more accurate and efficient Erythrocyte Sedimentation Tubes, driving the Erythrocyte Sedimentation Tube market size and contributing to its growth forecast.

The rising prevalence of chronic diseases, such as inflammation and autoimmune disorders, has increased the demand for diagnostic tests, including those that utilize Erythrocyte Sedimentation Tubes, thereby fueling market growth.

Restraints2 items

The high cost of Erythrocyte Sedimentation Tubes and the equipment required to analyze them can be a significant barrier to adoption, particularly in resource-constrained settings, limiting the Erythrocyte Sedimentation Tube market growth.

The lack of standardization in Erythrocyte Sedimentation Tube manufacturing and testing protocols can lead to variability in results, which can impact the reliability and accuracy of diagnostic tests, thereby hindering market expansion.

Opportunities2 items

The increasing adoption of point-of-care testing and the development of portable Erythrocyte Sedimentation Tube analyzers are expected to drive growth in the Erythrocyte Sedimentation Tube market, particularly in emerging economies.

The growing demand for personalized medicine and targeted therapies has created opportunities for the development of innovative Erythrocyte Sedimentation Tube-based diagnostic tests, which can help drive market growth and increase the Erythrocyte Sedimentation Tube market size.

Challenges2 items

The Erythrocyte Sedimentation Tube market faces intense competition from alternative diagnostic tests, such as automated hematology analyzers, which can perform multiple tests simultaneously, potentially limiting the demand for Erythrocyte Sedimentation Tubes.

The need for skilled personnel to operate and interpret Erythrocyte Sedimentation Tube tests can be a challenge, particularly in areas with limited resources or inadequate training, affecting the growth forecast of the market.

Market Segmentation

Loading chart…

The Erythrocyte Sedimentation Tube market can be segmented based on Application, which includes various medical fields that utilize these tubes for diagnostic purposes. This segmentation contributes to the overall market size by highlighting the specific areas where Erythrocyte Sedimentation Tubes are most commonly used, such as in inflammatory disease diagnosis and cancer research. Understanding the application segment is crucial for market players to tailor their products and services to meet the demands of different medical specialties, ultimately driving growth in the Erythrocyte Sedimentation Tube segmentation.

Another significant segmentation of the Erythrocyte Sedimentation Tube market is by Types, which encompasses various subtypes such as [object Object] and [object Object]. This segmentation is vital as it allows manufacturers to focus on producing specific types of tubes that cater to different laboratory settings and research requirements. By analyzing the types segment, industry stakeholders can identify trends and opportunities in the market, thereby informing their strategic decisions and contributing to the overall market taxonomy.

Erythrocyte Sedimentation Tube Segmentation Breakdown7 items

Application

Hospital

Specialist Center

Other

Types

Plastic

Grass

Regional Insights

Loading chart…

The Erythrocyte Sedimentation Tube market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market, driven by factors such as high adoption of advanced medical technologies, favorable policies supporting healthcare infrastructure development, and significant investments in research and development.

The Asia Pacific region is expected to be the fastest-growing region, driven by increasing demographics and growing demand for diagnostic tests, improving infrastructure, and a maturing ecosystem that supports the development of the Erythrocyte Sedimentation Tube market. Europe is also expected to contribute significantly to the market growth, with key drivers including a high level of ecosystem maturity, significant investments in healthcare, and a large patient population.

In Latin America and the Middle East & Africa, the Erythrocyte Sedimentation Tube market growth is expected to be driven by increasing adoption of medical technologies, government policies supporting healthcare development, and growing investments in healthcare infrastructure. Overall, the regional forecast indicates a positive outlook for the Erythrocyte Sedimentation Tube market, with varying growth rates across regions.

Competitive Landscape

The Erythrocyte Sedimentation Tube market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Erythrocyte Sedimentation Tube competitive landscape is characterized by high competition, with companies focusing on differentiation through product portfolios, service models, and channel strength. Global players are driving innovation, while local companies are leveraging their regional presence and cost advantages.

Companies in this market are adopting various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to stay competitive. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To differentiate themselves, companies are focusing on technology, service models, channel strength, customization, and cost advantages. The following companies are examples of this strategic focus:

BD: regional expansion

Greiner Bio-One: premium pricing

DWK Life Sciences: OEM tie-ups

ELITechGroup: innovation pipeline

Thomas Scientific: local manufacturing

Streck: vertical integration

Key Erythrocyte Sedimentation Tube Companies18 items

Greiner Bio-One

DWK Life Sciences

ELITechGroup

Thomas Scientific

Streck

Geisinger Health System

SOL-Millennium

Hangzhou Hanshuo Medical Equipment

Zhejiang Gongdong Medical Equipment

ESBE Scientific Industries Inc.

Medline Industries, Inc.

Kartell Spa

SANLI Medical

DD Biolab

Vacutest Kima

Labcorp

AL-Hanoof

Market Ecosystem

The Erythrocyte Sedimentation Tube ecosystem encompasses a network of participants that create and capture value across the upstream, midstream, and downstream segments. This ecosystem includes technology providers, suppliers, integrators, channels, and end users, all of which contribute to the development, manufacturing, and distribution of Erythrocyte Sedimentation Tubes. The value chain analysis of this ecosystem reveals the complex interactions and relationships between these participants, highlighting how value is created and captured at each stage.

Raw material/component suppliers — provide essential materials

OEMs / manufacturers — design and produce Erythrocyte Sedimentation Tubes

Technology providers — develop innovative testing technologies

Distributors / channel partners — facilitate product distribution

Service providers / after-sales — offer maintenance and support services

End users / buyers — utilize Erythrocyte Sedimentation Tubes in medical settings

Regulators/standards bodies — establish guidelines and standards

The flow of value within the Erythrocyte Sedimentation Tube ecosystem is influenced by various control points, including regulatory approvals, technological advancements, and end-user adoption. Dependency risks, such as input constraints and standards compliance, can impact the ecosystem's efficiency. Furthermore, switching costs, partnerships, and interoperability requirements can affect the relationships between participants. The ecosystem's structure and dynamics may also differ by region, reflecting varying market conditions, regulatory environments, and user needs.

Recent Industry Insights

The Erythrocyte Sedimentation Tube industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing product offerings and expanding distribution networks. Notable mergers and acquisitions have also taken place, aimed at consolidating market share and improving competitiveness. Furthermore, several companies have launched innovative products and technologies, such as automated sedimentation systems, to improve testing efficiency and accuracy.

In addition to these developments, regulatory changes have emphasized the need for standardized testing procedures, driving the adoption of erythrocyte sedimentation tubes that meet stringent quality and safety requirements. Shifts in consumer and enterprise trends have also led to increased demand for convenient, user-friendly testing solutions. Moreover, funding rounds and expansions have enabled companies to invest in research and development, paving the way for future innovations in the Erythrocyte Sedimentation Tube industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Erythrocyte Sedimentation Tube market outlook. The market exhibits moderate attractiveness due to its niche applications in medical research and diagnostics. Competitive intensity is relatively low, with a few key players dominating the market. The long-term outlook appears promising, driven by increasing demand for precise diagnostic tools. The innovation landscape is characterized by gradual improvements in tube design and materials. However, the demand–supply balance may be affected by fluctuations in raw material prices and supply chain disruptions. Key risk factors include regulatory changes and intense competition from alternative diagnostic methods.

12 items

1. Executive Summary

2. Erythrocyte Sedimentation Tube Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Erythrocyte Sedimentation Tube Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Erythrocyte Sedimentation Tube Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Erythrocyte Sedimentation Tube Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Erythrocyte Sedimentation Tube Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Erythrocyte Sedimentation Tube Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Erythrocyte Sedimentation Tube Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Erythrocyte Sedimentation Tube Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Erythrocyte Sedimentation Tube Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Erythrocyte Sedimentation Tube Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Erythrocyte Sedimentation Tube Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Erythrocyte Sedimentation Tube Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Erythrocyte Sedimentation Tube Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Erythrocyte Sedimentation Tube Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Erythrocyte Sedimentation Tube Market Competition by Key Manufacturers

9.1. Global Erythrocyte Sedimentation Tube Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Erythrocyte Sedimentation Tube: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. BD

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Greiner Bio-One

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. DWK Life Sciences

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. ELITechGroup

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Thomas Scientific

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Streck

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Geisinger Health System

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. SOL-Millennium

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Hangzhou Hanshuo Medical Equipment

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Zhejiang Gongdong Medical Equipment

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. ESBE Scientific Industries Inc.

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Medline Industries, Inc.

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Kartell Spa

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. SANLI Medical

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. DD Biolab

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Vacutest Kima

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Labcorp

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. AL-Hanoof

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Erythrocyte Sedimentation Tube Market

Figure 4: Global Erythrocyte Sedimentation Tube Market: Drivers

Figure 5: Global Erythrocyte Sedimentation Tube Market: Challenges

Figure 6: Global Erythrocyte Sedimentation Tube Market: Trends

Figure 7: Global Erythrocyte Sedimentation Tube Market: Opportunity

Figure 8: Global Erythrocyte Sedimentation Tube Market: Restraint

Figure 9: Global Erythrocyte Sedimentation Tube Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Erythrocyte Sedimentation Tube Market Value (USD Million) By Region

Figure 19: Global Erythrocyte Sedimentation Tube Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Erythrocyte Sedimentation Tube Market Value (USD Million) By Region

Figure 27: Global Erythrocyte Sedimentation Tube Market Share (%) By: Regions (2032)

Figure 28: Global Erythrocyte Sedimentation Tube Market Volume (K) By Region

Figure 29: Global Erythrocyte Sedimentation Tube Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Erythrocyte Sedimentation Tube Market Value (USD Million) By Region

Figure 37: Global Erythrocyte Sedimentation Tube Market Share (%) By: Regions (2032)

Figure 38: Global Erythrocyte Sedimentation Tube Market Volume (K) By Region

Figure 39: Global Erythrocyte Sedimentation Tube Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

131 items

Table 1: Market Segmentation Analysis

Table 2: Global Erythrocyte Sedimentation Tube Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Erythrocyte Sedimentation Tube Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Erythrocyte Sedimentation Tube Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Erythrocyte Sedimentation Tube Market Value (USD Million) By Region

Table 14: Global Erythrocyte Sedimentation Tube Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Erythrocyte Sedimentation Tube Market Volume (K) By Region

Table 31: Global Erythrocyte Sedimentation Tube Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Erythrocyte Sedimentation Tube Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Erythrocyte Sedimentation Tube Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Erythrocyte Sedimentation Tube Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: BD Basic Information And Sales Area

Table 52: BD. Products Portfolio

Table 53: Greiner Bio-One Basic Information And Sales Area

Table 54: Greiner Bio-One. Products Portfolio

Table 55: DWK Life Sciences Basic Information And Sales Area

Table 56: DWK Life Sciences. Products Portfolio

Table 57: ELITechGroup Basic Information And Sales Area

Table 58: ELITechGroup. Products Portfolio

Table 59: Thomas Scientific Basic Information And Sales Area

Table 60: Thomas Scientific. Products Portfolio

Table 61: Streck Basic Information And Sales Area

Table 62: Streck. Products Portfolio

Table 63: Geisinger Health System Basic Information And Sales Area

Table 64: Geisinger Health System. Products Portfolio

Table 65: SOL-Millennium Basic Information And Sales Area

Table 66: SOL-Millennium. Products Portfolio

Table 67: Hangzhou Hanshuo Medical Equipment Basic Information And Sales Area

Table 68: Hangzhou Hanshuo Medical Equipment. Products Portfolio

Table 69: Zhejiang Gongdong Medical Equipment Basic Information And Sales Area

Table 70: Zhejiang Gongdong Medical Equipment. Products Portfolio

Table 71: ESBE Scientific Industries Inc. Basic Information And Sales Area

Table 72: ESBE Scientific Industries Inc.. Products Portfolio

Table 73: Medline Industries, Inc. Basic Information And Sales Area

Table 74: Medline Industries, Inc.. Products Portfolio

Table 75: Kartell Spa Basic Information And Sales Area

Table 76: Kartell Spa. Products Portfolio

Table 77: SANLI Medical Basic Information And Sales Area

Table 78: SANLI Medical. Products Portfolio

Table 79: DD Biolab Basic Information And Sales Area

Table 80: DD Biolab. Products Portfolio

Table 81: Vacutest Kima Basic Information And Sales Area

Table 82: Vacutest Kima. Products Portfolio

Table 83: Labcorp Basic Information And Sales Area

Table 84: Labcorp. Products Portfolio

Table 85: AL-Hanoof Basic Information And Sales Area

Table 86: AL-Hanoof. Products Portfolio

Table 87: Global Market Value (USD Million) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Market Value (USD Million) (2025-2032) By Types

Table 90: Global Market Share (%) By Types (2032)

Table 91: Global Market Volume (K) (2025-2032) By Application

Table 92: Global Market Share (%) By Application (2032)

Table 93: Global Market Volume (K) (2025-2032) By Types

Table 94: Global Market Share (%) By Types (2032)

Table 95: Global Erythrocyte Sedimentation Tube Market Value (USD Million) By Region

Table 96: Global Erythrocyte Sedimentation Tube Market Share (%) By Region (2025-2032)

Table 97: North America Market Value (USD Million) (2025-2032) By Country

Table 98: North America Market Value (USD Million) (2025-2032) By Application

Table 99: North America Market Value (USD Million) (2025-2032) By Types

Table 100: Europe Market Value (USD Million) (2025-2032) By Country

Table 101: Europe Market Value (USD Million) (2025-2032) By Application

Table 102: Europe Market Value (USD Million) (2025-2032) By Types

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 104: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 105: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 106: South America Market Value (USD Million) (2025-2032) By Country

Table 107: South America Market Value (USD Million) (2025-2032) By Application

Table 108: South America Market Value (USD Million) (2025-2032) By Types

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 110: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 111: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 112: Global Erythrocyte Sedimentation Tube Market Volume (K) By Region

Table 113: Global Erythrocyte Sedimentation Tube Market Share (%) By Region (2025-2032)

Table 114: North America Market Volume (K) (2025-2032) By Country

Table 115: North America Market Volume (K) (2025-2032) By Application

Table 116: North America Market Volume (K) (2025-2032) By Types

Table 117: Europe Market Volume (K) (2025-2032) By Country

Table 118: Europe Market Volume (K) (2025-2032) By Application

Table 119: Europe Market Volume (K) (2025-2032) By Types

Table 120: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 121: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 122: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 123: South America Market Volume (K) (2025-2032) By Country

Table 124: South America Market Volume (K) (2025-2032) By Application

Table 125: South America Market Volume (K) (2025-2032) By Types

Table 126: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 127: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 128: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 129: Research Programs/Design For This Report

Table 130: Key Data Information From Secondary Sources

Table 131: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Erythrocyte Sedimentation Tube Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.94 billion
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Greiner Bio-One; DWK Life Sciences; ELITechGroup; Thomas Scientific; Streck; Geisinger Health System; SOL-Millennium; Hangzhou Hanshuo Medical Equipment; Zhejiang Gongdong Medical Equipment; ESBE Scientific Industries Inc.; Medline Industries, Inc.; Kartell Spa; SANLI Medical; DD Biolab; Vacutest Kima; Labcorp; AL-Hanoof
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Erythrocyte Sedimentation Tube Segmentation Breakdown7 items

Application

Hospital

Specialist Center

Other

Types

Plastic

Grass

Regional Insights

Loading chart…

Competitive Landscape

BD: regional expansion

Greiner Bio-One: premium pricing

DWK Life Sciences: OEM tie-ups

ELITechGroup: innovation pipeline

Thomas Scientific: local manufacturing

Streck: vertical integration

Key Erythrocyte Sedimentation Tube Companies18 items

Greiner Bio-One

DWK Life Sciences

ELITechGroup

Thomas Scientific

Streck

Geisinger Health System

SOL-Millennium

Hangzhou Hanshuo Medical Equipment

Zhejiang Gongdong Medical Equipment

ESBE Scientific Industries Inc.

Medline Industries, Inc.

Kartell Spa

SANLI Medical

DD Biolab

Vacutest Kima

Labcorp

AL-Hanoof

Market Ecosystem

Raw material/component suppliers — provide essential materials

OEMs / manufacturers — design and produce Erythrocyte Sedimentation Tubes

Technology providers — develop innovative testing technologies

Distributors / channel partners — facilitate product distribution

Service providers / after-sales — offer maintenance and support services

End users / buyers — utilize Erythrocyte Sedimentation Tubes in medical settings

Regulators/standards bodies — establish guidelines and standards

Recent Industry Insights

Analyst Overview

Table of Contents